×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 ... [108]
内容类型
期刊论文 [99]
会议论文 [9]
发表日期
2019 [22]
2018 [22]
2017 [14]
2016 [16]
2015 [17]
2014 [5]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共108条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Treatment Optimization for Brain Metastasis from Anaplastic Lymphoma Kinase Rearrangement Non-Small-Cell Lung Cancer
期刊论文
2019, 页码: 1-8
作者:
Wang Wenhui
;
Sun Xin
;
Hui Zhouguang
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2020/01/03
Anaplastic lymphoma kinase
Brain metastasis
Non-small-cell lung cancer
Radiation therapy
Tyrosine kinase inhibitor
Second-generation EGFR and ErbB tyrosine kinase inhibitors as first-line treatments for non-small cell lung cancer
期刊论文
2019, 卷号: 12, 页码: 6535-6548
作者:
Wang, Shouzheng
;
Li, Junling
收藏
  |  
浏览/下载:46/0
  |  
提交时间:2020/01/03
afatinib
dacomitinib
epidermal growth factor receptor
non-small-cell lung cancer
Design, synthesis and biological evaluation of novel 4-anilinoquinazoline derivatives as hypoxia-selective EGFR and VEGFR-2 dual inhibitors
期刊论文
2019, 卷号: 181, 页码: 111552
作者:
Wei Huiqiang
;
Duan Yuqing
;
Gou Wenfeng
;
Cui Jie
;
Ning Hongxin
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
3-Nitro-1
2
4-triazole
EGFR
Hypoxia
Tyrosine kinase inhibitor
VEGFR-2
Vandetanib
Phase II study of antiangiogenic tyrosine kinase inhibitor apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative advanced breast cancer
会议论文
CANCER RESEARCH, 2019-02-01
作者:
Zhu, A.
;
Yuan, P.
;
Wang, J.
;
Fan, Y.
;
Luo, Y.
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2020/01/03
Phase II study of antiangiogenic tyrosine kinase inhibitor apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative advanced breast cancer
期刊论文
2019, 卷号: 79, 期号: 4
作者:
Zhu, A.
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
Comparative review of drug-drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer
期刊论文
2019, 卷号: 12, 页码: 5467-5484
作者:
Xu, Zi-Yi
;
Li, Jun-Ling
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/01/03
drug metabolism
pharmacokinetics
CYP450
UDP-glucuronosyltransferase
P-glycoprotein
Neratinib-based therapy in patients with metastatic HER2-positive breast cancer from Asia
期刊论文
2019
作者:
Xu Binghe
;
Kim Sung-Bae
;
Inoue Kenichi
;
Lee JuRueyJiuan
;
Zhang Bo
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
Asia
HER2
efficacy
metastatic breast cancer
neratinib
pooled analysis
safety
tyrosine kinase inhibitor
The Efficacy of Upfront Intracranial Radiation with TKI Compared to TKI Alone in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases
期刊论文
2019, 卷号: 10, 期号: 9, 页码: 1985-1990
作者:
Wang, Chunyu
;
Lu, Xiaotong
;
Zhou, Zongmei
;
Wang, Jingbo
;
Hui, Zhouguang
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2020/01/03
non-small cell lung cancer
EGFR mutation
brain metastases
radiation
tyrosine kinase inhibitors
Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy or non-small cell lung cancer
期刊论文
2019, 卷号: 11, 期号: 5, 页码: 1779-+
作者:
Liu, Yu-Tao
;
Han, Xiao-Hong
;
Xing, Pu-Yuan
;
Hu, King-Sheng
;
Hao, Xue-Zhi
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
Non-small cell lung cancer (NSCLC)
circular RNA (circRNA)
epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)
predictive biomarker
Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer
期刊论文
2019, 卷号: 15, 期号: 21, 页码: 2489-2501
作者:
Iwata Hiroji
;
Masuda Norikazu
;
Kim Sung-Bae
;
Inoue Kenichi
;
Rai Yoshiaki
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/01/03
Asia
HER2
early stage breast cancer
efficacy
extended adjuvant therapy
neratinib
safety
tyrosine kinase inhibitor
©版权所有 ©2017 CSpace - Powered by
CSpace